Alaunos Therapeutics TCRT
NASDAQ TCRT
$2.96 -0.01 (-0.34%)
As of: Oct 21, 2026 · 11:41 AM EDT

Alaunos Therapeutics (TCRT) Restructuring Costs (2023)

Updated

Alaunos Therapeutics' Restructuring Costs was $850,000 in Q4 2023, up 102.9% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Restructuring Costs (2023) Analysis & Trends

For FY2023, Restructuring Costs at Alaunos Therapeutics came in at $1.27 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Alaunos Therapeutics 7.17 Mn 3.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 850,000.00
Sep 30, 2023 419,000.00
API Access

Alaunos Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=TCRT&period=max&api_key=YOUR_API_KEY